The Role of Anti-Inflammatory Drugs in Respiratory Diseases - Pirfenidone, Penicillamine, Chloroquine and Chlorambucil

Author(s): Benjamin Courchia, Aya Gozlan, Maor Waldman, Or Kalchiem-Dekel

Journal Name: Current Respiratory Medicine Reviews

Volume 9 , Issue 5 , 2013

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


It is well established that inflammation plays a central role in the pathophysiology of chronic obstructive pulmonary disease (COPD), asthma and interstitial lung diseases (ILD). A wide variety of triggers may induce the recruitment and activation of inflammatory cells in the airways and stimulate both innate and adaptive immune mechanisms. Airway inflammation is implicated in many of the clinical characteristics of both entities. Basal levels of inflammatory mediators are often elevated during exacerbations, as a manifestation of the underlying process. Idiopathic pulmonary fibrosis (IPF) is a life-threatening variant of ILD. In IPF chronic injury and excessive apoptosis of alveolar epithelial type II (AECII) cells occurs, leading to permanently perturbed epithelial homeostasis. Treatment modalities aiming to attenuate epithelial injury are currently in early pre-clinical development and may reach the clinical arena in only a few years.

This review will focus on four drugs: pirefendinone, penicillamine, chloroquine, and chlorambucil. These agents have demonstrated immunomodulatory effects through different pathways. We will describe their mechanisms of action, side effects, and their potential use in various pulmonary diseases based on available clinical data. Unfortunately their current use is restricted due to limited efficacy, paucity of randomized clinical trials, and side effects resulting in a relatively narrow therapeutic index. Future trials will determine their exact role in the management of the various pulmonary diseases under discussion.

Keywords: Chlorambucil, chloroquine, interstitial lung diseases, penicillamine, pirfenidone.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Page: [334 - 343]
Pages: 10
DOI: 10.2174/1573398X10666140526234959
Price: $65

Article Metrics

PDF: 24